Astec Lifesciences Ltd Share Price Today - Astec Lifesciences Ltd Stock Price Live NSE/BSE

Astec Lifesciences Ltd

NSE: ASTEC BSE: 533138

₹540.60

(-6.76%)

Wed, 08 Apr 2026, 09:24 am

MTF 5xInvest in Astec Lifesciences Ltd with 5x Leverage Buy with MTF

Market Cap12.02B

PE Ratio0

Dividend0

Process Industries

Chemicals: Agricultural

24.5K

Astec Lifesciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1207.47
Net Profit
-134.71
P/B
5.64
Sector P/E
26.01
P/E
-9.82
EV/EBITDA
0
Debt/Equity (Industry)
0.61
Interest Cover (Industry)
2.85
ROCE (Industry)
5.78
RONW (Industry)
3.94
ROE
-44.60
ROCE
-12.60
Debt/Equity
1.74
EPS (TTM)
0
Dividend Yield
0
Book Value
185.77
Interest Cover
-2.84

Analysis

all

Pros

Astec LifeSciences's earnings growth is expected to exceed the low risk savings rate of 7.2%.
Astec LifeSciences's earnings are expected to exceed the low risk growth rate next year.
Performance (ROE) is expected to be above the current IN Chemicals industry average.
Astec LifeSciences's revenue growth is expected to exceed the India market average.
Astec LifeSciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Cons

Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
No need to calculate the sustainability of Astec LifeSciences's dividends as it is not paying a notable one for India.
Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
Astec LifeSciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Astec LifeSciences's dividend is below the markets top 25% of dividend payers in India (3.08%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	71.97	72.42	70.87	70.87	66.75
FII	0.04	0.00	0.02	0.25	1.20
DII	3.17	4.01	4.26	4.34	5.41
Public	24.82	23.57	24.84	24.54	26.64
Government	0	0	0	0	0

Technical Analysis

RSI

43.48

MACD

-20.23

50 DMA

601.52

200 DMA

739.64

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	838.87	703.27	621.93	567.67	486.33	432.07	296.47
Fibonacci	703.27	651.47	619.47	567.67	515.87	483.87	432.07
Camarilla	577.89	565.46	553.03	567.67	528.17	515.74	503.31

Pivots Level: Classic

+271.20

838.87

+135.60

703.27

+54.27

621.93

567.67

Pivot Point

LTP: 550.75

-81.33

486.33

-135.60

432.07

-271.20

296.47

Moving Average

SMAEMA

Period

Value

10-EMA
556.28
20-EMA
572.23
30-EMA
584.54
50-EMA
604.68
100-EMA
646.43
200-EMA
711.62

Announcement Date	Purpose	Action	Ex Date
30 Jan 2026	board-meetings	Quarterly Results, Nine Months Results
29 Oct 2025	board-meetings	Quarterly Results
30 Jun 2025	rights	1:7 Rights Issue of Equity Shares	04 Jul 2025
04 Jun 2025	rights	Right Issue of Equity Shares	04 Jul 2025
23 Apr 2025	agm
23 Jun 2024	agm	Annual General Meeting	24 Jul 2024
02 May 2024	agm
21 Jun 2023	dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share	22 Jul 2023
02 May 2023	dividend	₹1.50 Dividend /Share	22 Jul 2023
02 May 2023	agm

Astec Lifesciences Ltd

Sumitomo Chemical India Ltd

UPL Ltd

Sharda Cropchem Ltd

Dhanuka Agritech Ltd

P I Industries Ltd

Astec Lifesciences Ltd About

Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.

Industry

Pesticides / Agrochemicals - Indian

Founded

1994

Headquarters

CEO

N B Godrej

Employees

Contact

Website

http://www.godrejastec.com

ipo@godrejastec.com; astecinfo@godrejastec.com; as

Phone

91-22-25188010

Location

GodrejOne 3rd Fl Pirojshanagar, Vikhroli (E) Eastern Exp Highw, Mumbai, Maharashtra, 400079

Year	History
2018	Astec Lifesciences Ltd Wins Indian Chemical Council (ICC) Award For Excellence In Management Astec Lifesciences Ltd amalgamated with Godrej Agrovet Limited
2019	Astec Lifesciences Ltd was awarded ICC Award for Excellence in Human Resource Management
2020	Astec Lifesciences Ltd is stake entire equity in Astec Europe Sprl
2021	Astec LifeSciences Limited commenced commercial production at its new Herbicide plant at Mahad
2023	Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development. Astec LifeSciences launches R&D Center to develop new crop protection formulations.

Client Name	Order Side	QTY	Avg Price	Date
NK SECURITIES RESEARCH PRIVATE LIMITED	Sell	220260	600.16	25 Mar 2026
NK SECURITIES RESEARCH PRIVATE LIMITED	Buy	220551	599.54	25 Mar 2026
MATHISYS ADVISORS LLP	Buy	122049	733.8	09 Dec 2025
HRTI PRIVATE LIMITED	Sell	146811	735.08	09 Dec 2025
MATHISYS ADVISORS LLP	Sell	119613	732.42	09 Dec 2025
HRTI PRIVATE LIMITED	Buy	155505	737.56	09 Dec 2025
MUSIGMA SECURITIES	Buy	184208	852.13	03 Dec 2025
JUNOMONETA FINSOL PRIVATE LIMITED	Buy	473088	850.91	03 Dec 2025
QE SECURITIES LLP	Buy	146098	849.71	03 Dec 2025
HRTI PRIVATE LIMITED	Buy	310871	849.65	03 Dec 2025

Astec Lifesciences Ltd News

Astec LifeSciences Pays Rs.4.36 Cr Interest on NCDs

Astec LifeSciences Limited successfully made timely interest payment of Rs.4,36,10,000/- on its Non-Convertible Debentures with ISIN INE563J08023 on March 27, 2026, as per scheduled due date.

28 Mar 2026

companies

Astec LifeSciences Gets Credit Rating Reaffirmation

ICRA Limited reaffirmed Astec LifeSciences' credit ratings across multiple facilities totaling Rs.1,068 Crore, maintaining AA- and A1+ ratings with negative outlook on long-term facilities.

25 Mar 2026

companies

Astec LifeSciences Divests Stake in Clean Max Andes

Astec LifeSciences has sold its complete 26% equity stake in Clean Max Andes Private Limited for Rs.26,000/-, exiting its investment in the solar power special purpose vehicle.

09 Mar 2026

co actions results

Astec LifeSciences Allots 577 Shares Under ESOP

Astec LifeSciences allotted 577 equity shares upon exercise of stock options under ESOP 2012, raising Rs. 12,970 and increasing paid-up capital to Rs. 22,28,22,380.

24 Feb 2026

co actions results

Astec Lifesciences Q3 Loss Narrows to ₹157M

Astec Lifesciences reported reduced consolidated net loss of ₹157M in Q3 compared to ₹404M loss in previous year, while revenue grew 33% to ₹1.25B from ₹939M year-on-year.

30 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800